Stage III Renal Cell Cancer Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0028847 (Stage III Renal Cell Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs